
Palo Alto Networks revenue advances to $3.44 billion, up 39%
Key points
- Palo Alto Networks reported fiscal first-quarter 2027 revenue of $3.44 billion, up 39% year over year, while adjusted diluted earnings per share reached $1.05.
- Next-Generation Security annual recurring revenue increased 66% to $9.73 billion, and remaining performance obligations rose 35% to $21.0 billion.
- Palo Alto Networks raised its full-year financial outlook, forecasting revenue of $14.52 billion–$14.57 billion and adjusted diluted earnings per share of $4.26–$4.30, alongside its planned acquisition of Applied Compute.
Palo Alto Networks (NASDAQ:PANW) reported fiscal first-quarter 2027 revenue of $3.44 billion, up 39% year over year, while non-GAAP diluted earnings per share reached $1.05 for the quarter ended October 31, 2026.
Revenue exceeded analyst expectations of approximately $3.31 billion, while non-GAAP earnings per share topped the consensus estimate of $0.97
GAAP net income increased to $482 million, or $0.57 per diluted share, from $334 million, while GAAP operating income fell to $96 million from $309 million and non-GAAP operating income increased to $1.1 billion from $746 million.
Palo Alto Networks raised its fiscal 2027 revenue outlook to $14.52 billion–$14.57 billion and non-GAAP diluted earnings guidance to $4.26–$4.30 per share.
Next-Generation Security annual recurring revenue increased 66% to $9.73 billion, while remaining performance obligations rose 35% to $21 billion, with subscription and support revenue contributing $2.85 billion of quarterly sales.
Palo Alto Networks also announced its intention to acquire Applied Compute, a platform for post-training and inference of open-weight AI models, in an all-stock transaction reportedly valued at approximately $4.5 billion, extending its strategy to secure enterprise AI adoption.
Frequently asked questions
More from United States
Woodward records 22% sales growth in fiscal 2026 as revenue hits $4.4B
C3is reports $1.2 million Q3 net loss as revenue rises
Cosmos Health revenue hits $53.6 million, up 17.6%
Summit launches Phase III lung cancer trial for ivonescimab
DataMeds AI issues 630,000 shares in cancer partnership
CoinShares net income improves 27% to $39.6 million



